‘Is this what happens when you’re on POT,’ asks Ramya on PM Modi’s TOP priority

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Thiruvananthapuram, Apr 10: Kerala Chief Minister Pinarayi Vijayan on Friday said that it has been 100 days since the first COVID-19 case was reported and shared the updated figures of positive cases, along with the efforts made by the state government to contain the virus.

"100 Days of #COVID19 | Kerala Story It's been 100 days since the first case was reported. 258 active cases, 97 recovered, Total confirmed: 357 Deaths: 2. 12,710 samples tested Special COVID-19 Hospital, 1,251 Community Kitchens, 28,08,650 Individuals Served, 3,676 Destitutes Rehabilitated," Vijayan tweeted.

India's first case was reported in Kerala in January. The patient was a student, who was studying at Wuhan University in China.

Meanwhile, the Ministry of Health and Family Welfare on Friday informed that India's total number of COVID-19 positive cases now stands at 6,412. Out of these, 5,709 are active patients and 504 of them have been cured/discharged and migrated.

With 30 new deaths reported in the last 12 hours, the death toll has reached 199.

Mangaluru, May 4: The district administration has set up seven check-posts to monitor those entering Dakshina Kannada from other districts and states amidst coronavirus crisis.

The check-posts are located at up seven check-posts at Talapady, Hejamady, Gundya, Jalsoor, Charmadi, Naravi and Kallugundi. 

According to Deputy Commissioner Sindhu B Rupesh, all those who enter the district will be screened. Those who come from outside the district and state will be asked to remain in quarantine. 

As the relaxation is announced for 12 hours, the public should be cautious while venturing out of the house. Wearing a mask in public is mandatory in addition to maintaining social distance. 

Further, she said of the 24 cases reported in the district, only four had symptoms of breathlessness and others were asymptomatic. Of the nine active cases in the district, the condition of one patient is serious while two are likely to be discharged from hospital shortly, said the DC.